Shockwave Javelin

Lead the charge with our first-of-its-kind Forward Intravascular Lithotripsy (IVL) Platform. It’s Shockwave peripheral IVL redefined to modify and cross calcified occlusive disease above and below the knee.

Download Tech Sheet See Shockwave Peripheral IVL Reimbursement
Product image of the Shockwave generator and Shockwave Javelin Peripheral IVL catheter
Product image of the Shockwave generator and Shockwave Javelin Peripheral IVL catheter

Shockwave Javelin Peripheral logo

Shockwave Javelin: Crack & Cross Calcified Occlusive Disease

Get Shockwave IVL closer to occlusive calcium than ever before with Shockwave Javelin.* Its non-balloon-based design and single distal emitter enable you to modify and cross tight, challenging lesions, while minimizing complications like distal embolization.

  • First-of-its-kind Forward IVL platform transforms treatment of difficult-to-cross lesions

    With a forward emitter situated within an IVL window, it’s uniquely designed to address challenging lesions where other devices may be unable to cross.

  • Single distal emitter delivers energy & cracks calcium beyond the tip

    Located in the tip of the catheter, the emitter’s spherical energy enables cracking of calcium in front of the catheter.**

  • Proven safety & efficacy profile consistent with Balloon IVL platform

    This novel device leverages robust clinical data around the safety and efficacy of Shockwave IVL’s mechanism of action.†1, 2, 3, 4
Close-up image of the Shockwave Javelin Peripheral IVL catheter tip, including the single distal emitter and reinforced catheter shaft. Image includes illustrated sonic pressure waves to show how energy is delivered beyond the tip of the catheter

How to Use Shockwave Javelin

  • Illustrated image demonstrating how the Shockwave Javelin Peripheral IVL Catheter is delivered to a calcified lesion within the vasculature, without the need for a balloon or inflation

    Step One

    Deliver the Shockwave Javelin Catheter to the calcified occlusion – no balloon, no inflation necessary.
  • Illustrated image demonstrating how gentle forward pressure is applied while the Shockwave Javelin Peripheral IVL Catheter generates sonic pressure waves to crack calcified lesions ahead of the catheter within the vasculature

    Step Two

    Apply gentle forward pressure while generating sonic pressure waves to crack calcium ahead of the catheter.
  • Illustrated image demonstrating how the Shockwave Javelin Peripheral IVL Catheter advances through the vasculature and crosses a previously uncrossable calcified lesion

    Step Three

    Advance the catheter and cross the previously difficult-to-cross lesion.
  • Illustrated image demonstrating how the Shockwave Javelin Peripheral IVL Catheter creates a lumen within the vasculature to enable therapy

    Step Four

    A small lumen is created to enable definitive therapy of choice.
Shockwave Javelin Peripheral Animation

See Shockwave Javelin in Action

Get Shockwave IVL closer to occlusive calcium than ever before with a distal emitter that emanates spherical energy extending beyond the tip.**

Shockwave Javelin Specifications

Illustration graphic showing the parts of the Shockwave Javelin Peripheral IVL catheter, including details of the emitter, IVL window, catheter shaft and catheter hub
Catalog Number Crossing Profile (in) Sheath Compatibility (Fr) Guidewire Compatibility Catheter Working Length (cm) Pulses/Cycle Cycles Pulses (Max)
JVNPIVLF 1.5 5 0.014 150 10 12 120

Forward PAD IDE/Feasibility Studies

Shockwave Javelin safely and effectively modifies calcium to cross heavily calcified and severely stenosed above-the-knee (ATK) and below-the-knee (BTK) lesions.1, 2

Safe & Effective for Crossing Heavily Calcified Lesions & Severely Stenosed Vessels

Statistics Callout

This section presents key statistical information with numbers and descriptions.

  • 93
    %
    Crossing success
  • 95
    %
    Moderate-to-severe calcification

Safe Calcium Treatment Option, Consistent with Commercially Available Balloon-Based IVL with Low Rates of Angiographic Complications & Major Adverse Events (MAE)

Statistics Callout

This section presents key statistical information with numbers and descriptions.

  • 1.2
    %
    Post-Shockwave Javelin serious angiographic complication rate
  • 4.1
    %
    Post-dilation serious angiographic complication rate
  • 1.0
    %
    Final serious angiographic complication rate
  • 1.1
    %
    MAE at 30 days

Effective Calcium Treatment Option, Consistent with Commercially Available Balloon-Based IVL with Similar Diameter Stenosis Reduction

Statistics Callout

This section presents key statistical information with numbers and descriptions.

  • 83
    %
    Pre-procedure diameter stenosis
  • 59
    %
    Post-Shockwave Javelin diameter stenosis
  • 31
    %
    Post-dilation diameter stenosis
  • 23
    %
    Final diameter stenosis

Shockwave Javelin Case Reviews

Explore Education Library

Shockwave Javelin Peripheral Resources

Explore All Products

*Based on internal product specifications comparing existing Shockwave Peripheral IVL devices.
**Internal testing shows a spherical sonic output from distal emitter consistent with previous Shockwave balloon-based IVL emitters, with sonic output extending beyond the tip of the catheter.
†Internal testing shows a spherical sonic output from distal emitter consistent with previous Shockwave balloon-based IVL emitters.

1: Corl JD, Clair D, Mwipatayi P, et al. FORWARD PAD IDE/Feasibility Studies: Primary Endpoint Analysis of a Novel Non- Balloon-Based Peripheral IVL Catheter. JACC: Cardiovascular Interventions. Published online November 4, 2024. doi:10.1016/j.jcin.2024.10.035.
2: Corl J, VIVA Late Breaking Clinical Trial 2024.
3: Tepe, Gunnar et al. Intravascular Lithotripsy for Peripheral Artery Calcification: Mid-term Outcomes From the Randomized Disrupt PAD III Trial. Journal of the Society for Cardiovascular Angiography & Interventions, Volume 1, Issue 4, 100341. July-August, 2022.
4: Armstrong EJ, Adams G, Soukas PA, et al. Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Disrupt PAD III Observational Study. Journal of Endovascular Therapy. 2024;0(0). doi:10.1177/15266028241283716.